Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Optimal initial dose of orally administered once-daily extended-release tacrolimus following intravenous tacrolimus therapy after liver transplantation.

Mita A, Ikegami T, Masuda Y, Katsuyama Y, Ohno Y, Urata K, Nakazawa Y, Kobayashi A, Miyagawa S.

Transplant Proc. 2014 Apr;46(3):794-6. doi: 10.1016/j.transproceed.2014.01.006.

PMID:
24767351
2.

Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.

Kim SH, Lee SD, Kim YK, Park SJ.

Hepatobiliary Pancreat Dis Int. 2015 Aug;14(4):374-9.

PMID:
26256081
3.

Once-daily tacrolimus in living donor liver transplant recipients.

Sugawara Y, Miyata Y, Kaneko J, Tamura S, Aoki T, Sakamoto Y, Hasegawa K, Yamashiki N, Kokudo N.

Biosci Trends. 2011 Aug;5(4):156-8. doi: 10.5582/bst.2011.v5.4.156.

4.

Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation.

Beckebaum S, Iacob S, Sweid D, Sotiropoulos GC, Saner F, Kaiser G, Radtke A, Klein CG, Erim Y, de Geest S, Paul A, Gerken G, Cicinnati VR.

Transpl Int. 2011 Jul;24(7):666-75. doi: 10.1111/j.1432-2277.2011.01254.x. Epub 2011 Apr 5.

5.

Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism.

Uchida J, Kuwabara N, Machida Y, Iwai T, Naganuma T, Kumada N, Nakatani T.

Transplant Proc. 2012 Jan;44(1):128-33. doi: 10.1016/j.transproceed.2011.11.005.

PMID:
22310596
6.

Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients.

Uchida J, Iwai T, Kabei K, Machida Y, Kuwabara N, Naganuma T, Kumada N, Nakatani T.

Transplant Proc. 2014;46(2):532-6. doi: 10.1016/j.transproceed.2013.11.146.

PMID:
24656005
7.

Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients.

Heffron TG, Pescovitz MD, Florman S, Kalayoglu M, Emre S, Smallwood G, Wisemandle K, Anania C, Dhadda S, Sawamoto T, Keirns J, Fitzsimmons W, First MR.

Am J Transplant. 2007 Jun;7(6):1609-15.

8.

Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.

Ruangkanchanasetr P, Sanohdontree N, Supaporn T, Sathavarodom N, Satirapoj B.

Ann Transplant. 2016 Dec 16;21:765-774.

9.

Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.

Alloway RR, Eckhoff DE, Washburn WK, Teperman LW.

Liver Transpl. 2014 May;20(5):564-75. doi: 10.1002/lt.23844. Epub 2014 Mar 26.

10.

Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up.

Giannelli V, Rossi M, Giusto M, Lucidi C, Lattanzi B, Ruffa A, Ginanni Corradini S, Mennini G, Melandro F, Lai Q, Berloco P, Merli M.

Eur Rev Med Pharmacol Sci. 2013 Oct;17(20):2718-20.

11.

Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.

Nakamura Y, Takeuchi H, Okuyama K, Akashi T, Jojima Y, Konno O, Akashi I, Hama K, Iwahori T, Ashizawa T, Hirano T, Oka K, Matsuno N, Nagao T.

Transplant Proc. 2005 May;37(4):1725-7.

PMID:
15919445
12.

A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.

Hatakeyama S, Fujita T, Yoneyama T, Yoneyama T, Koie T, Hashimoto Y, Saitoh H, Funyu T, Narumi S, Ohyama C.

Transplant Proc. 2012 Jan;44(1):121-3. doi: 10.1016/j.transproceed.2011.11.022.

PMID:
22310594
13.

Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation.

Yano S, Mori S, Saito T, Yokoyama H, Machishima T, Shimada T, Yahagi Y, Sugiyama K, Ogasawara Y, Takahara S, Kasama K, Katsube A, Kamiyama Y, Suzuki K, Inui Y, Usui N, Aiba K, Yamashita T.

Ann Hematol. 2015 Mar;94(3):491-6. doi: 10.1007/s00277-014-2233-7. Epub 2014 Oct 19.

PMID:
25325985
14.

Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan.

Uemoto S, Abe R, Horike H, So M.

Transplant Proc. 2014 Apr;46(3):749-53. doi: 10.1016/j.transproceed.2013.11.071.

PMID:
24767340
15.

Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.

Me├žule A, Tinti F, Poli L, Bachetoni A, Umbro I, Nofroni I, Lai Q, Pretagostini R, Berloco PB, Mitterhofer AP.

Transplant Proc. 2011 May;43(4):1024-7. doi: 10.1016/j.transproceed.2011.02.049.

PMID:
21620042
16.

Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.

Shuker N, Cadogan M, van Gelder T, Roodnat JI, Kho MM, Weimar W, Hesselink DA.

Ther Drug Monit. 2015 Apr;37(2):262-9. doi: 10.1097/FTD.0000000000000136.

PMID:
25265255
17.

Once-daily prolonged-release tacrolimus in de novo liver transplantation: a single center cohort study.

Marubashi S, Wada H, Kobayashi S, Eguchi H, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H.

Hepatogastroenterology. 2012 Jun;59(116):1184-8. doi: 10.5754/hge11623.

PMID:
22172333
18.

Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan.

Takahashi K, Abe R, Usuki S, So M.

Transplant Proc. 2014;46(2):406-10. doi: 10.1016/j.transproceed.2013.11.072.

PMID:
24655975
19.

Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations.

Coilly A, Calmus Y, Chermak F, Dumortier J, Duvoux C, Guillaud O, Houssel-Debry P, Neau-Cransac M, Stocco J.

Liver Transpl. 2015 Oct;21(10):1312-21. doi: 10.1002/lt.24228. Review.

20.

A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.

Song GW, Lee SG, Hwang S, Kim KH, Kim WJ, Sin MH, Yoon YI, Tak EY.

Exp Clin Transplant. 2016 Aug;14(4):412-8. doi: 10.6002/ect.2015.0227. Epub 2016 Mar 14.

Supplemental Content

Support Center